» Authors » Jose G Moreno

Jose G Moreno

Explore the profile of Jose G Moreno including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 311
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Moreno J, Gomella L
Urology . 2019 Jun; 132:1-9. PMID: 31207303
We reviewed the literature for the biologic, prognostic, and predictive significance of circulating prostate cancer tumor cells (CTCs), and circulating tumor DNA in the blood of metastatic castration resistant prostate...
2.
Kalra P, Leech J, Tirado S, Moreno J
J Endourol . 2010 Mar; 24(6):947-8. PMID: 20345273
Robot-assisted partial nephrectomy is associated with a learning curve, necessitating proficiency in robotic renal dissection, hilar control, and subsequent mass excision and renorrhaphy. The Gelport can be used during these...
3.
Smirnov D, Zweitzig D, Foulk B, Miller M, Doyle G, Pienta K, et al.
Cancer Res . 2005 Jun; 65(12):4993-7. PMID: 15958538
Metastases from primary tumors are responsible for most cancer deaths. It has been shown that circulating tumor cells (CTCs) can be detected in the peripheral blood of patients with a...
4.
Moreno J, Miller M, Gross S, Allard W, Gomella L, Terstappen L
Urology . 2005 Apr; 65(4):713-8. PMID: 15833514
Objectives: To determine whether circulating tumor cells (CTCs) predict for survival in patients with metastatic prostate cancer (PCa) and to compare its prognostic abilities with other clinical factors. Methods: Blood...
5.
Larson C, Moreno J, Pienta K, Gross S, Repollet M, OHara S, et al.
Cytometry A . 2004 Oct; 62(1):46-53. PMID: 15472900
Background: The prescence of circulating tumor cells (CTCs) in the peripheral blood of cancer patients and their frequency has been correlated with disease status. Methods: In this study, CTCs were...
6.
OHara S, Moreno J, Zweitzig D, Gross S, Gomella L, Terstappen L
Clin Chem . 2004 Feb; 50(5):826-35. PMID: 14988224
Background: Circulating tumor cells (CTCs) represent a surrogate source of tissue and conceptually represent a "real-time" biopsy. We previously reported that the number of CTCs mirrors disease progression in hormone-refractory...